Abstract
Jelka Hartwig, Franziska Sotzny, Sandra Bauer, Gabriela Riemekasten, Duska Dragun, Claudia Dames, Patricia Grabowski, Carmen Scheibenbogen
Abstract
Authors
Institutions
Provenance
crossref
Confidence 100%
ror
Confidence 99%
pubmed
Confidence 98%
europepmc
Confidence 96%
openalex
Confidence 95%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
The beta2-adrenergic receptor controls inflammation by driving rapid IL-10 secretion
10.1016/j.bbi.2018.09.004 · 2018
Unresolved referenced work
1995
Infection elicited autoimmunity and myalgic encephalomyelitis/chronic fatigue syndrome: an explanatory model
10.3389/fimmu.2018.00229 · 2018
GPCR-specific autoantibody signatures are associated with physiological and pathological immune homeostasis
10.1038/s41467-018-07598-9 · 2018
Myalgic encephalomyelitis: international consensus criteria
10.1111/j.1365-2796.2011.02428.x · 2011
Onset patterns and course of myalgic encephalomyelitis/chronic fatigue syndrome
10.3389/fped.2019.00012 · 2019
Autoimmune mediated G-protein receptor activation in cardiovascular and renal pathologies
10.1160/th08-10-0710 · 2009
An fc gamma receptor-mediated upregulation of the production of interleukin 10 by intravenous immunoglobulin in bone-marrow-derived mouse dendritic cells stimulated with lipopolysaccharide in vitro
2013
Catecholamines increase monocyte TNF receptors and inhibit TNF through beta 2-adrenoreceptor activation
1997
Disturbed neuroendocrine-immune interactions in chronic fatigue syndrome
2000
Autoantibodies and cardiac arrhythmias
10.1016/j.hrthm.2011.06.032 · 2011
Autoimmune basis for postural tachycardia syndrome
2014
The role of the beta2 adrenergic receptor on endothelial progenitor cells dysfunction of proliferation and migration in chronic obstructive pulmonary disease patients
10.1517/14728222.2013.773975 · 2013
Antibodies to beta adrenergic and muscarinic cholinergic receptors in patients with chronic fatigue syndrome
10.1016/j.bbi.2015.09.013 · 2016
Intravenous immunoglobulin G-mediated inhibition of T-cell proliferation reflects an endogenous mechanism by which IgG modulates T-cell activation
10.1016/j.clim.2009.04.002 · 2009
Chronic fatigue syndrome and the immune system: where are we now?
10.1016/j.neucli.2017.02.002 · 2017
Intravenous immunoglobulin preparation attenuates LPS-induced production of pro-inflammatory cytokines in human monocytic cells by modulating TLR4-mediated signaling pathways
10.1007/s00210-012-0765-8 · 2012
Symptoms of autonomic dysfunction in chronic fatigue syndrome
10.1093/qjmed/hcm057 · 2007
The beta2-adrenergic receptor on T and B lymphocytes: do we understand it yet?
10.1016/j.bbi.2011.08.001 · 2012
Immunoadsorption to remove ss2 adrenergic receptor antibodies in Chronic Fatigue Syndrome CFS/ME
10.1371/journal.pone.0193672 · 2018
COMPASS 31: a refined and abbreviated composite autonomic symptom score
10.1016/j.mayocp.2012.10.013 · 2012
Myalgic encephalomyelitis/chronic fatigue syndrome - evidence for an autoimmune disease
10.1016/j.autrev.2018.01.009 · 2018
Autoantibodies against muscarinic cholinergic receptor in chronic fatigue syndrome
2003
Agonist-like beta-adrenoceptor antibodies in heart failure
10.1016/s0002-9149(99)00265-9 · 1999
Agonistic autoantibodies directed against G-protein-coupled receptors and their relationship to cardiovascular diseases
10.1007/s00281-014-0425-9 · 2014
Altered neuroendocrine control and association to clinical symptoms in adolescent chronic fatigue syndrome: a cross-sectional study
10.1186/s12967-016-0873-1 · 2016
No additional external references are available.